FCMC accepts for further evaluation AS “Rīgas

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FCMC accepts for further evaluation AS “Rīgas Farmaceitiskā fabrika” mandatory takeover bid

Financial and Capital Market Commission (FCMC) on December 10, 2014 has accepted for further processing application for AS “Rīgas Farmaceitiskā fabrika” mandatory takeover bid by SIA ''CAPITAL HOLDING''.

Information about the mandatory takeover bid:

SIA “CAPITAL HOLDING” (registration number 40103782514, registration date April 24, 2014, legal address: Ganību dambis 24D, Riga, LV-1005). Offerer owns 550 422 (83,02%) AS “Rīgas Farmaceitiskā fabrika” shares. Helēna Livšica owns 100% of SIA “CAPITAL HOLDING”. Helena Livsiča indirectly owns more than 50% of AS “Rīgas Farmaceitiskā fabrika” shares, therefore the company owned by Helena Livsiča announces the mandatory takeover bid.

Type of the share takeover bid: mandatory takeover bid

The price of one share in prospectus is set at: EUR 1.56

Term of takeover bid : takeover bid for AS “Rīgas Farmaceitiskā fabrika” shares will last for 30 days, starting on the day when SIA “CAPITAL HOLDING” will publish official announcement in the official journal “Latvijas Vēstnesis” informing about the mandatory takeover bid. The mandatory takeover offer will come in force only after the according decision is made by FCMC on allowing to announce the mandatory takeover bid.

Nasdaq Baltic
Issuer Services
+371 67212431
www.nasdaqbaltic.com

Nasdaq Baltic ir vienots nosaukums, ko lieto, lai apzīmētu uzņēmumus un biržas/regulētos tirgus un alternatīvos tirgus First North, kurus pārvalda NASDAQ OMX grupā ietilpstošie Baltijas valstīs esošie uzņēmumi, t.i. NASDAQ OMX Tallinn AS, NASDAQ OMX Riga, AS un AB NASDAQ OMX Vilnius.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Angel Oak Mortgage Trust 2025-1 Receives Preliminary Ratings

Updated Category News Views 195

Angel Oak Mortgage Trust 2025-1 Ratings Overview KBRA has recently assigned preliminary ratings to various classes of mortgage-backed certificates associated with Angel Oak Mortgage Trust 2025-1 (AOMT 2025-1). This substantial transaction amounts to $342.0 million and comprises non-prime residential mortgage-backed securities (RMBS). It encompasses a pool of 631...

Continue Reading
Eagle Bancorp Montana Reports Positive Q3 Performance Growth

Updated Category News Views 177

Eagle Bancorp Montana's Strong Q3 Earnings Report Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), the parent entity of Opportunity Bank of Montana, recently shared its financial results for the latest quarter. With net income reaching $2.7 million, or $0.34 per diluted share, this marks an upward trend from the previous quarter’s income of $1.7 million, equivalent to $0.22...

Continue Reading
Consumer Resilience Fuels Bank of America Amidst Slowing Trends

Updated Category News Views 310

Bank of America's Performance Overview Bank of America (NYSE: BAC) has reported a mixed performance in recent times, showing resilience in its earnings even as some sectors experience challenges. The bank's stock opened slightly higher, reflecting a cautious optimism in the market with shares trading around $46.50. For the quarter, Bank of America generated $26.6 billion...

Continue Reading
The Setai St. Maarten: A New Era in Caribbean Luxury

Updated Category News Views 136

The Setai St. Maarten: A Feast for the Senses In a stunning location along the coast, The Setai St. Maarten emerges as a jewel of luxury, introducing a captivating blend of elegance and tranquility to the Caribbean. This exciting new resort is poised to redefine the standards of Caribbean hospitality, creating unforgettable experiences for guests in a picturesque coastal...

Continue Reading
Cullinan Therapeutics Gears Up for Major Healthcare Events

Updated Category News Views 142

Cullinan Therapeutics Hosts Exciting Events at Major Conferences CAMBRIDGE, Mass. — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a prominent biopharmaceutical firm, is set to engage the investment community with notable events at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting and the Jefferies 2025 Global Healthcare Conference. These gatherings...

Continue Reading